20/20 Biolabs, Inc. (AIDX) announced that its stockholders have approved a charter amendment to increase the number of authorized shares of its common stock from 50 million to 500 million. The proposal was passed at the company's adjourned annual meeting held on September 16, 2026.
Key Details
- Authorized Share Increase: The number of authorized shares of common stock, par value $0.01, will increase from 50,000,000 to 500,000,000.
- Voting Results: The proposal was approved with 3,028,609 votes for, 1,155,607 against, and 72,621 abstentions.
- Meeting Date: The vote was finalized at the Adjourned Annual Meeting on September 16, 2026, after being postponed from the original August 18, 2026 meeting.